Brief: Ceapro Inc Reports Q1 Results
20/05/2021 14:36
May 20 (Reuters) - Ceapro Inc CZO.V :
* Q1 SALES ROSE 10% TO C$4.702 MILLION ($3.89 MILLION)
Source text for Eikon: ID:nGNX1mLXhZ
Further company coverage: CZO.V
($1 = 1.2083 Canadian dollars)
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases